Can-Fite BioPharma Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q2 2024 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q3 2024 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q4 2024 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 0 | $0.00 | $0.00 | $0.00 |
Can-Fite BioPharma Ltd. Earnings Date And Information
Can-Fite BioPharma Ltd. last posted its earnings results on Thursday, October 3rd, 2024. The company reported $-0.4 earnings per share for the quarter, missing analysts' consensus estimates of $-0.4 by $0. The company had revenue of 158,000 for the quarter and had revenue of 743,000 for the year. Can-Fite BioPharma Ltd. has generated $0 earnings per share over the last year ($-0.006 diluted earnings per share) and currently has a price-to-earnings ratio of -2.05. Can-Fite BioPharma Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 28th, 2024 based on prior year's report dates.
Can-Fite BioPharma Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2024 | Q2 2024 | -$0.00 | $300,000 | $158,000 | ||
| 03/28/2024 | Q1 2024 | -$0.27 | -$0.00 | 0.27 | $158,000 | |
| 03/28/2024 | Q4 2023 | -$0.27 | -$0.00 | 0.27 | $155,000 | |
| 11/30/2023 | Q3 2023 | -$0.43 | -$0.00 | 0.43 | $200,000 | $196,000 |
| 06/01/2023 | Q2 2023 | -$0.42 | -$0.00 | 0.42 | $200,000 | $196,000 |
| 06/01/2023 | Q1 2023 | -$0.42 | -$0.00 | 0.42 | $196,000 | |
| 03/30/2023 | Q4 2022 | -$0.57 | -$0.00 | 0.57 | $197,000 | |
| 11/25/2022 | Q3 2022 | -$1.00 | -$0.00 | 1 | $300,000 | $204,000 |
| 06/29/2022 | Q2 2022 | -$0.00 | $250,000 | $204,000 | ||
| 03/24/2022 | Q1 2022 | -$1.80 | -$0.00 | 1.8 | $205,000 | |
| 11/26/2021 | Q4 2021 | -$1.00 | -$0.01 | 0.99 | $204,000 | |
| 11/26/2021 | Q3 2021 | -$1.00 | -$0.01 | 0.99 | $140,000 | $251,000 |
| 06/29/2021 | Q2 2021 | -$0.01 | $218,333 | $250,000 | ||
| 03/25/2021 | Q1 2021 | -$1.30 | -$0.00 | 1.3 | $148,000 | |
| 11/30/2020 | Q4 2020 | -$2.50 | -$0.01 | 2.49 | $150,000 | |
| 11/30/2020 | Q3 2020 | -$2.50 | -$0.01 | 2.49 | $500,000 | $211,000 |
| 06/29/2020 | Q2 2020 | -$0.01 | $250,000 | $204,000 | ||
| 03/31/2020 | Q1 2020 | -$0.03 | $198,000 | |||
| 11/29/2019 | Q4 2019 | -$5.80 | -$0.04 | 5.76 | $192,000 | |
| 11/29/2019 | Q3 2019 | -$5.80 | -$0.03 | 5.77 | $1.15 M |
Can-Fite BioPharma Ltd. Earnings: Frequently Asked Questions
-
When is Can-Fite BioPharma Ltd.'s earnings date?
Can-Fite BioPharma Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 28th, 2024 based off last year's report dates.
-
How can I listen to Can-Fite BioPharma Ltd.'s earnings conference call?
The conference call for Can-Fite BioPharma Ltd.'s latest earnings report can be listened to online.
-
How can I read Can-Fite BioPharma Ltd.'s conference call transcript?
The conference call transcript for Can-Fite BioPharma Ltd.'s latest earnings report can be read online.
-
How much revenue does Can-Fite BioPharma Ltd. generate each year?
Can-Fite BioPharma Ltd. (:CANF) has a recorded annual revenue of $743,000.
-
How much profit does Can-Fite BioPharma Ltd. generate each year?
Can-Fite BioPharma Ltd. (:CANF) has a recorded net income of $743,000. Can-Fite BioPharma Ltd. has generated $-0.006 earnings per share over the last four quarters.
-
What is Can-Fite BioPharma Ltd.'s price-to-earnings ratio?
Can-Fite BioPharma Ltd. (:CANF) has a price-to-earnings ratio of -2.05 and price/earnings-to-growth ratio is -0.07.
